Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.34    -0.11 (-2.47%)
Bid:
4.335
Ask:
4.35
Spread: 0.015 (0.346%)
Market Cap: £208.30m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Directorate Change

18 Oct 2006 11:04

Seeing Machines Limited18 October 2006 18th October 2006 Seeing Machines Limited ("Seeing Machines" or the "Company") Seeing Machines Directorate Changes The Board of Directors of Seeing Machines Limited (AIM : SEE) announces: • the appointment of Mr William Mobbs as an independent Non-Executive Director effective 18 October 2006 • the resignation of Mr Anthony Kinnear as a Director of Seeing Machines effective 30 November 2006 Commenting on Mr Kinnear's resignation, Fulton Muir, Chairman of Seeing Machinessaid: "Mr Kinnear has made a significant contribution to Seeing Machines both as adirector and as CEO up until his resignation from that position in September2005. He saw the company through a challenging time and played a key role inthe success of the IPO and the Board would like to thank him for hiscontribution to the Company and wish him well." Mr Mobbs, aged 47, is currently the CEO and co-founder of ITL Limited, an ASXlisted company, with over 10 years experience developing, manufacturing,marketing and selling product into the global medical and healthcare industry.Mr Mobbs has a strong track record for successfully turning product R&D intocommercial outcome in the medical and healthcare markets and this is ofparticular relevance to Seeing Machines given the development of the glaucomadiagnostic device and other potential opportunities in these markets. Commenting on Mr Mobbs appointment, Fulton Muir, Chairman of Seeing Machinessaid: "The company is very pleased to appoint a director with a significant trackrecord of success and experience in a field directly relevant to SeeingMachines. I'm sure Mr Mobbs will make a significant contribution to our effortsto commercialise the company's R&D particularly the glaucoma diagnostic device." The information required to be disclosed in accordance with the AIM rules, withrespect to the appointment of Mr Mobbs to the board, is set out in Appendix 1. Enquiries:Seeing Machines Limited Insinger de Beaufort Parkgreen CommunicationsNick Cerneaz, CEO Simon Fox Justine Howarth / Victoria Thomas+61 (0) 2 6125 6501 +44 (0) 20 7190 7018 +44 (0) 20 7493 3713www.seeingmachines.com Appendix 1 Set out below are the current and past Directorships over the past five years ofMr William Leonard Mobbs (aged 47):- Current Directorships Former Directorships (within past 5 years) Bilbo Holdings Pty Ltd GP Innovations Pty Ltd Hastcombe Pty Ltd Hygenia Corporation Pty Ltd ITL Corporation Pty Ltd ITL Needle Guard Corporation Pty Ltd ITL Design & Manufacturing Pty Ltd ITL Healthcare Pty Ltd ITL Ltd Noble House Group Pty Ltd Surgicare Pty Ltd The Company confirms that no other details are required to be disclosed underparagraph G of Schedule 2 of the AIM Rules with respect to Mr Mobbs. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Apr 202512:00 pmRNS-RSeeing Machines Announces 3D Camera Technology
31st Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Mar 20257:00 amRNSDirector/PDMR Shareholding
27th Mar 20257:11 amRNSBoard Changes
27th Mar 20257:08 amRNSHalf year results and financial report
26th Mar 20258:15 amRNSHolding(s) in Company
24th Mar 20257:00 amRNS-RNew Technology and Safety Leadership Appointments
21st Mar 20257:59 amRNSLondon Town Hall presentation to be live streamed
3rd Mar 202510:18 amRNSNotification of Major Holdings
27th Feb 20257:00 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNSH1 FY2025 Trading Update & Quarterly KPIs
24th Feb 20257:00 amRNSMitsubishi Electric Automotive America Agreement
18th Feb 20257:00 amRNSLondon Presentation
23rd Jan 20257:00 amRNSDirector dealing
21st Jan 20257:00 amRNSDirector/PDMR Shareholding
20th Jan 20257:00 amRNSDirector/PDMR Shareholding
15th Jan 20257:00 amRNSDirector/PDMR Shareholding
15th Jan 20257:00 amRNSDirector/PDMR Shareholding
14th Jan 20257:11 amRNSDirector/PDMR Shareholding
10th Jan 20257:00 amRNSPDMR / Director Dealing
3rd Jan 20257:00 amRNSHolding(s) in Company
31st Dec 202412:27 pmRNSHolding(s) in Company
31st Dec 20248:00 amRNSHolding(s) in Company
31st Dec 20248:00 amRNSPDMR/PCA Dealing
31st Dec 20248:00 amRNSDirector/PDMR Shareholding
31st Dec 20248:00 amRNSDirector/PDMR Shareholding
30th Dec 20247:00 amRNSHolding(s) in Company
30th Dec 20247:00 amRNSDirector/PDMR Shareholding
23rd Dec 20247:00 amRNS£26.2 million strategic investment from Mitsubishi
19th Dec 20247:00 amRNSIssue of Equity and Total Voting Rights
12th Dec 20243:00 pmRNSFY2024 Annual Report
4th Dec 20247:00 amRNS-RLaunch of 2023-24 Guardian Insights Report
27th Nov 20248:49 amRNSResult of AGM
21st Nov 20248:30 amRNSIssue of Shares and Total Voting Rights
11th Nov 20247:00 amRNSQ1 FY2025 Quarterly KPIs
4th Nov 20247:00 amRNSNotice of Annual General Meeting
31st Oct 20247:00 amRNSGlobal regulatory momentum drives revenue growth
17th Oct 20247:00 amRNSNotice of Full Year Results 2024
28th Aug 20247:00 amRNSSeeing Machines FY24 Trading Update
8th Aug 20247:00 amRNSSeeing Machines (SEE) Q4 FY2024 Quarterly KPIs
8th Jul 20247:00 amRNSSeeing Machines acquires Asaphus Vision GmbH
26th Jun 20247:00 amRNSFive year License Renewal with Caterpillar
7th May 20247:00 amRNSQ3 FY2024 Quarterly KPIs
2nd May 202410:30 amRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSAutomotive Program Extension to 2032
26th Apr 202411:00 amRNSDirector/PDMR Shareholding
25th Mar 20248:06 amRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSHalf year results and financial report
28th Feb 20247:00 amRNSNotice of Results
8th Feb 20247:00 amRNSH1 FY2024 Trading Update & Quarterly KPIs

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.